Drug and pharmaceutical recalls

354 federal recalls in the last 12 months. Federal recalls for prescription drugs, OTC medications, supplements, and pharmaceuticals. Sourced from the FDA and translated into plain English.

Recent recalls

Page 5 of 12
  • PEMRYDI RTU pemetrexed injection recalled for discoloration

    Certain vials of PEMRYDI RTU (pemetrexed injection) have developed green to dark green discoloration. The affected lots are P400172 and PA00050A, expiring 09/30/2027. Discoloration may indicate a quality issue with the medication.

    ModerateFDAAug 26, 2026Shilpa Medicare2 products

  • Baxter saline injection recalled for fiberglass contamination

    Baxter is recalling two lots of 0.9% Sodium Chloride Injection (saline solution) used in hospitals and dialysis centers because fiberglass particles have been found in the solution. The affected lots were distributed to hospitals and medical suppliers in 14 states between July 31 and August 3, 2026. No injuries have been reported so far.

    SeriousFDAAug 25, 2026Baxter

  • Baxter dextrose injection recalled for stainless steel particles

    Baxter is recalling one lot of 70% Dextrose Injection used in hospitals and care facilities because stainless steel particles were found in the solution. If given intravenously, these particles could cause blood clots, block blood vessels, or damage organs. No patient injuries have been reported so far.

    SeriousFDAAug 25, 2026Baxter

  • Vitruvias Therapeutics Thyroid Tablets recalled for potential superpotency

    Vitruvias Therapeutics is recalling one lot (504950) of Thyroid Tablets, USP 30 mg because testing found the tablets may contain higher-than-intended amounts of thyroid hormone. Taking overly potent thyroid medication can cause an overactive thyroid, leading to weight loss, rapid heartbeat, chest pain, and other serious symptoms, especially in elderly people, pregnant women, and infants.

    ModerateFDAAug 21, 2026Vitruvias Therapeutics

  • Optimal Balance Pharmacy glutathione injection recalled for endotoxin risk

    Optimal Balance Pharmacy identified elevated bacterial endotoxin levels in one lot of compounded glutathione 200 mg/mL multi-dose vials during testing. Endotoxins can cause fevers, low blood pressure, severe allergic reactions, and in serious cases, death. The pharmacy has already received reports of adverse events including fever, chills, severe headache, nausea, vomiting, and allergic-like reactions.

    SeriousFDAAug 19, 2026Optimal Balance Pharmacy

  • B. Braun Lactated Ringers recalled for particulate matter

    B. Braun Medical Inc. is recalling one lot of Excel Lactated Ringers Injection (1000mL) distributed to hospitals and healthcare facilities because the solution contains small particles—primarily cellulose fibers from cotton, wood, and polystyrene. These particles could cause blood clots, vein inflammation, or organ damage if infused intravenously. No injuries have been reported so far.

    SeriousFDAAug 19, 2026Excel

  • Baxter Cefazolin injection recalled for particulate matter

    Baxter Healthcare Corporation is recalling one lot of Cefazolin in Dextrose injection due to the presence of particulate matter in the solution. The affected product is a frozen premix infusion bag used for intravenous antibiotic treatment. This is a Class I recall, the most serious classification.

    SeriousFDAAug 19, 2026Baxter

  • Optiray ioversol injection recalled for particulate matter

    Liebel-Flarsheim Company LLC is recalling Optiray Imaging Bulk Package-350 (ioversol injection 74%, 350 mg/mL) due to the presence of particulate matter—including plastic, stainless steel, and glass—found in affected vials. The contamination affects lot #25ZF3670 with an expiration date of May 31, 2027, distributed nationwide in the US and Mexico.

    SeriousFDAAug 19, 2026Liebel-Flarsheim

  • Victory Medical Center glutathione recalled for microbial contamination

    Victory Medical Center Pharmacy's Glutathione injectable solution (200 mg/mL) failed sterility testing and was found to contain elevated bacterial endotoxin levels, which are out of acceptable limits. The affected product was distributed nationwide in specific lots with expiration dates through August 2026.

    SeriousFDAAug 19, 2026Victory Medical Center Pharmacy

  • Kian Pee Wan Capsules recalled for undeclared dexamethasone, cyproheptadine

    Buy-Herbal's Kian Pee Wan Capsules contain two prescription drug ingredients—dexamethasone and cyproheptadine—that are not listed on the label and were not approved by the FDA. The product was sold online through eBay. No injuries have been reported.

    SeriousFDAAug 19, 2026Buy-Herbal

  • Heritage clindamycin oral solution recalled for foreign substance

    Heritage Pharmaceuticals' clindamycin palmitate hydrochloride oral solution (75 mg/5 mL) has been recalled due to the presence of particles and white flakes found in reconstituted bottles. The affected lot is 2411550, which expires November 2026. This product was distributed nationwide.

    ModerateFDAAug 19, 2026Heritage Pharmaceuticals

  • Clear Eyes Maximum Itchy Eye Relief recalled for potential contamination

    CLEAR EYES Maximum Itchy Eye Relief eye drops may not be sterile due to potential contamination. The affected product is the 0.5 fl oz (15 mL) dropper bottle, Lot 2552A with expiration date 09/30/2027. No injuries have been reported.

    ModerateFDAAug 19, 2026Prestige Brands

  • Shoolin Pharma sildenafil and tadalafil powders recalled for manufacturing violations

    Shoolin Pharma Chem LLP is recalling five bulk powder products, sildenafil citrate and tadalafil in 100-gram, 500-gram, and 1-kilogram sizes, sold for prescription compounding only. The recall was triggered by manufacturing practice (CGMP) deviations found during an FDA inspection, and no injuries have been reported. The products were distributed nationwide.

    ModerateFDAAug 19, 2026Shoolin Pharma Chem5 products

  • Apollo Care semaglutide vials recalled for particulate matter

    Apollo Care is recalling 11 strengths of semaglutide sterile multi-dose vials for subcutaneous injection, all sold under the APOLLO care brand. The vials may contain particles identified as nylon/polyamide and silk-like material. The recall covers products distributed nationwide, and no injuries have been reported.

    ModerateFDAAug 19, 2026Apollo Care11 products

  • Diovan 160 mg tablets recalled for failed dissolution specifications

    One lot of Novartis Diovan (valsartan) 160 mg tablets failed to meet dissolution specifications, which means the tablets may not dissolve properly in the body. This could affect how well the medication works. The affected lot (AV5913C, expiring 6/2027) was distributed nationwide.

    ModerateFDAAug 19, 2026Novartis

  • Zydus mirabegron extended-release tablets recalled for N-nitroso impurity

    Zydus Pharmaceuticals is recalling one lot of Mirabegron Extended-Release 25 mg tablets due to higher-than-acceptable levels of N-Nitroso Mirabegron impurity. This impurity can potentially increase long-term health risks with continued use. No injuries have been reported.

    ModerateFDAAug 12, 2026Zydus

  • Sunny Pharmtech cyclophosphamide recalled for stainless steel particulate

    Cyclophosphamide for Injection, USP (1 gram/vial) manufactured by Sunny Pharmtech Inc. for Long Grove Pharmaceuticals may contain stainless steel particulate matter. The contamination was identified in two specific lots before distribution was completed.

    SeriousFDAAug 12, 2026Sunny Pharmtech2 products

  • Central Admixture pediatric TPN bags recalled for formulation error

    Central Admixture Pharmacy Services Inc. has recalled two patient-specific pediatric Total Parenteral Nutrition (TPN) bags due to incorrect product formulation. The affected bags were compounded with the wrong nutrient mixture. The recall affects only two prescriptions distributed in Georgia with lot numbers 20-1535990-0-1 and 20-1535892-0-1 (expiration July 16, 2026).

    ModerateFDAAug 12, 2026Central Admixture Pharmacy Services

  • Aurobindo Dicyclomine capsules recalled for empty capsules

    Aurobindo Pharma USA is recalling Dicyclomine Hydrochloride Capsules 10mg (Batch DMC125018A, expiration 07/2027) because some bottles contain empty capsules instead of the medication. The issue affects approximately 6,408 bottles distributed nationwide.

    ModerateFDAAug 12, 2026Aurobindo Pharma

  • Fresenius Kabi Tyenne injection recalled for glass particles

    Fresenius Kabi recalled one lot of Tyenne (tocilizumab-aazg) Injection 400 mg/20 mL vials after discovering the product contains glass particles. The affected lot was distributed nationwide to hospitals, clinics, and distributors.

    SeriousFDAAug 10, 2026Fresenius Kabi

  • VMC compounded glutathione vials recalled for elevated endotoxin

    Victory Medical Center Pharmacy identified elevated bacterial endotoxin levels in certain lots of its compounded glutathione 200 mg/mL multi-dose vials used for injection. Endotoxin contamination can cause serious reactions including fever, low blood pressure, severe headache, and in rare cases, anaphylactic shock or death. The pharmacy has received reports of adverse events from patients who received the product.

    SeriousFDAAug 5, 2026Victory Medical Center Pharmacy

  • Ascend dabigatran capsules recalled for failed impurity specification

    Ascend Laboratories is recalling one lot of dabigatran etexilate 150 mg capsules. Stability testing at 12 months found out-of-specification results for Impurity II, Impurity III, and total impurities. No injuries have been reported.

    FDAAug 5, 2026Ascend Laboratories3 products

  • Mylan mycophenolate mofetil injection recalled for precipitate

    Mylan Pharmaceuticals is recalling one lot of mycophenolate mofetil for injection vials because of the presence of precipitate, which is solid material that has separated out of the liquid. The recall covers 5,688 single-dose vials distributed nationwide. No injuries have been reported.

    ModerateFDAAug 5, 2026Mylan

  • Glenmark azelaic acid gel recalled for abnormal texture

    Glenmark Pharmaceuticals is recalling certain lots of Azelaic Acid Gel, 15%, 50-gram tubes, after customers reported grainy, gritty, or sandy texture. The FDA classifies this as a quality problem with the product's manufacturing process. No injuries have been reported.

    ModerateFDAAug 5, 2026Glenmark

  • Micro Labs dorzolamide-timolol eye drops recalled for container defect

    Micro Labs USA Inc. recalled dorzolamide HCl and timolol maleate ophthalmic solution (2%/0.5%, 10 mL bottle) because the firm received complaints of broken cap spikes and undeliverable drops. The notice reports no injuries.

    ModerateFDAAug 5, 2026Micro Labs USA

  • Fresenius Kabi Morphine syringes recalled for wrong opioid in packaging

    Fresenius Kabi recalled one lot of Morphine Sulfate Injection 2 mg/1 mL prefilled syringes due to a labeling error. Packages labeled as morphine may actually contain Dilaudid (hydromorphone), a different and more potent opioid. Using the wrong medication could cause serious respiratory problems or death, especially in patients not used to opioids or those with lung disease.

    SeriousFDAAug 4, 2026Fresenius Kabi

  • OPTIRAY contrast agent recalled for particulate matter

    Liebel-Flarsheim Company is recalling one lot of OPTIRAY Imaging Bulk Package 350 (a radiographic contrast agent used in hospitals and imaging centers) because it contains particulate matter including plastic, stainless steel, and glass fragments. No adverse events have been reported so far, but contaminated product could cause local irritation, swelling, or in serious cases, blood vessel blockage or clots.

    ModerateFDAJul 31, 2026Liebel-Flarsheim

  • American Regent Adequan injections recalled for glass fibers

    American Regent, Inc. Animal Health recalled four specific lots of Adequan Canine Injection (for dogs) and Adequan i.m. Injection (for horses) after discovering glass fibers in the products during internal testing. No adverse events have been reported to date.

    ModerateFDAJul 31, 2026American Regent

  • Trokendi XR topiramate capsules recalled for failed dissolution

    Supernus Pharmaceuticals is recalling one lot of Trokendi XR (topiramate extended-release capsules, 25 mg, 30 count) because it failed dissolution specifications. The FDA has classified the recall as Class III, and no injuries have been reported.

    ModerateFDAJul 29, 2026Supernus

  • Bionpharma divalproex sodium tablets recalled for foreign tablets

    Bionpharma Inc. is recalling 500 mg divalproex sodium delayed-release tablets because the bottles have foreign tablets or capsules in them. No injuries have been reported. The recall covers one lot sold nationwide.

    ModerateFDAJul 29, 2026Bionpharma

Explore other recall topics